Long-term outcomes of subcallosal cingulate deep brain stimulation for treatment-resistant depression / Andrea L. Crowell en The American Journal of Psychiatry, Año 2019 - Vol. 176 - No. 11 (Noviembre)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2019 - Vol. 176 - No. 11 (Noviembre) . - pp. 949-956 Título : Long-term outcomes of subcallosal cingulate deep brain stimulation for treatment-resistant depression Tipo de documento: texto impreso Autores: Andrea L. Crowell, Autor ; Patricio Riva-Posse, Autor ; Paul E. Holtzheimer, Autor Fecha de publicación: 2020 Artículo en la página: pp. 949-956 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos del estado de ánimo - unipolar, Trastorno depresivo mayor, Estimulación cerebral profunda, Estudios de resultados Resumen: Deep brain stimulation of the subcallosal cingulate (SCC DBS) has been studied as a potential treatment for severe and refractory major depressive disorder since 2005. The authors used an open-label, long-term follow-up design to examine participants enrolled in a clinical trial of SCC DBS for treatment-resistant depression. Link: ./index.php?lvl=notice_display&id=23092 [artículo] Long-term outcomes of subcallosal cingulate deep brain stimulation for treatment-resistant depression [texto impreso] / Andrea L. Crowell, Autor ; Patricio Riva-Posse, Autor ; Paul E. Holtzheimer, Autor . - 2020 . - pp. 949-956. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2019 - Vol. 176 - No. 11 (Noviembre) . - pp. 949-956 Palabras clave: Trastornos del estado de ánimo - unipolar, Trastorno depresivo mayor, Estimulación cerebral profunda, Estudios de resultados Resumen: Deep brain stimulation of the subcallosal cingulate (SCC DBS) has been studied as a potential treatment for severe and refractory major depressive disorder since 2005. The authors used an open-label, long-term follow-up design to examine participants enrolled in a clinical trial of SCC DBS for treatment-resistant depression. Link: ./index.php?lvl=notice_display&id=23092

Neuromodulation strategies for the treatment of depression / Susan K. Conroy en The American Journal of Psychiatry, Año 2021 - Vol. 178 - No.12 (Diciembre)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2021 - Vol. 178 - No.12 (Diciembre) . - pp. 1082-1088 Título : Neuromodulation strategies for the treatment of depression Tipo de documento: texto impreso Autores: Susan K. Conroy, Autor ; Paul E. Holtzheimer, Autor Fecha de publicación: 2022 Artículo en la página: pp. 1082-1088 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Neuroestimulación, Trastornos depresivos, Neuroestimulación, ECT, Neuroestimulación, Estimulación del nervio vago Resumen: For many decades, psychiatric treatment has been primarily guided by two major paradigms of psychopathology: a neurochemical paradigm leading to the development of medications and a psychological paradigm resulting in the development of psychotherapies. A third paradigm positing that psychiatric dysfunction results from abnormal communication within a network of brain regions that regulate mood, thought, and behavior has gained increased attention over the past several years and underlies the development of multiple neuromodulation and neurostimulation therapies. Link: ./index.php?lvl=notice_display&id=28279 [artículo] Neuromodulation strategies for the treatment of depression [texto impreso] / Susan K. Conroy, Autor ; Paul E. Holtzheimer, Autor . - 2022 . - pp. 1082-1088. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2021 - Vol. 178 - No.12 (Diciembre) . - pp. 1082-1088 Palabras clave: Neuroestimulación, Trastornos depresivos, Neuroestimulación, ECT, Neuroestimulación, Estimulación del nervio vago Resumen: For many decades, psychiatric treatment has been primarily guided by two major paradigms of psychopathology: a neurochemical paradigm leading to the development of medications and a psychological paradigm resulting in the development of psychotherapies. A third paradigm positing that psychiatric dysfunction results from abnormal communication within a network of brain regions that regulate mood, thought, and behavior has gained increased attention over the past several years and underlies the development of multiple neuromodulation and neurostimulation therapies. Link: ./index.php?lvl=notice_display&id=28279

---

1 (1 - 2 / 2)